Cabazitaxel in Platinum Refractory Ovarian Cancer

NCT01747239 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Too low inclusion rate. Only 4 patients included over 16 months

Conditions

Ovarian Cancer

Interventions

DRUG: Cabazitaxel

Sponsor

Vejle Hospital

Collaborators

[object Object]